- Home
- AEI vs AWH Comparison
AEI vs AWH Comparison
Compare AEI & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- AWH
- Stock Information
- Founded
- AEI 2014
- AWH 1993
- Country
- AEI United States
- AWH United States
- Employees
- AEI N/A
- AWH N/A
- Industry
- AEI Building operators
- AWH Medical/Dental Instruments
- Sector
- AEI Real Estate
- AWH Health Care
- Exchange
- AEI Nasdaq
- AWH Nasdaq
- Market Cap
- AEI 13.4M
- AWH 13.5M
- IPO Year
- AEI N/A
- AWH N/A
- Fundamental
- Price
- AEI $1.46
- AWH $0.85
- Analyst Decision
- AEI
- AWH Buy
- Analyst Count
- AEI 0
- AWH 2
- Target Price
- AEI N/A
- AWH $4.40
- AVG Volume (30 Days)
- AEI 74.2K
- AWH 62.2K
- Earning Date
- AEI 11-12-2024
- AWH 11-11-2024
- Dividend Yield
- AEI N/A
- AWH N/A
- EPS Growth
- AEI N/A
- AWH N/A
- EPS
- AEI N/A
- AWH N/A
- Revenue
- AEI $9,220,976.00
- AWH $8,923,000.00
- Revenue This Year
- AEI N/A
- AWH $15.59
- Revenue Next Year
- AEI N/A
- AWH $108.47
- P/E Ratio
- AEI N/A
- AWH N/A
- Revenue Growth
- AEI N/A
- AWH N/A
- 52 Week Low
- AEI $0.46
- AWH $0.74
- 52 Week High
- AEI $2.05
- AWH $6.01
- Technical
- Relative Strength Index (RSI)
- AEI 53.17
- AWH 49.98
- Support Level
- AEI $1.42
- AWH $0.76
- Resistance Level
- AEI $1.67
- AWH $0.89
- Average True Range (ATR)
- AEI 0.20
- AWH 0.07
- MACD
- AEI -0.01
- AWH 0.02
- Stochastic Oscillator
- AEI 41.10
- AWH 66.29
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.